Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Giuliano, GA"'
Autor:
Ruggenenti, P, Lauria, G, Iliev, IP, Fassi, A, Ilieva, AP, Rota, S, Chiurchiu, C, Barlovic, DP, Sghirlanzoni, A, Lombardi, R, Penza, P, CAVALETTI, GUIDO ANGELO, Piatti, ML, Frigeni, B, Filipponi, M, Rubis, N, Noris, G, Motterlini, N, Ene Iordache, B, Gaspari, F, Perna, A, Zaletel, J, Bossi, A, Dodesini, AR, TREVISAN, ROBERTO, Remuzzi, G, DEMAND Study Investigators, Parvanova, IA, Petrov, II, Yakymchuk, S, Arnoldi, F, Prandini, S, Kocijancic, A, Pongrac, D, Prezelj, J, Gala, T, Kersnik, M, Trevisan, G, Lepore, G, Mondo, E, Inversi, F, Mangili, R, Bruno, S, Brusegan, V, Lecchi, V, Belviso, A, Genovese, S, Pareyson, D, Camozzi, F, Cavaletti, G, Marzorati, L, MARMIROLI, PAOLA LORENA, Mattavelli, L, Tadini, S, Gherardi, G, Calini, W, Diadei, O, Rossoni, D, Villa, D, Carminati, S, Agus, E, Remuzzi, A, Giuliano, GA, Ganeva, M, Cannata, AN, Carrara, F, Cella, C, Centemeri, E, Ferrari, S, Petrò, C, Savoldelli, E, Stucchi, N, Boccardo, P, Perico, N, Peracchi, S, Gelmi, S, Mecca, G, Imbimbo, B, Alberici, M, Gardini, F, Lauria, G.
Publikováno v:
Hypertension. 58:776-783
To assess whether angiotensin-converting enzyme inhibitors and third-generation dihydropyridine calcium channel blockers ameliorate diabetic complications, we compared glomerular filtration rate (GFR; primary outcome), cardiovascular events, retinopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a233f19043e9a13e1ca319e1f03d913
https://doi.org/10.1161/hypertensionaha.111.174474
https://doi.org/10.1161/hypertensionaha.111.174474
Autor:
Ruggenenti P, Iliev I, Parvanova A, Perna A, Giuliano GA, Motterlini N, Ene Iordache B, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial, COSTA, GRAZIA MARIA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::5263f24a62aafc0ea3b1ef979f087935
http://hdl.handle.net/11585/71619
http://hdl.handle.net/11585/71619
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruggenenti P; Unit of Nephrology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Caruso MR; Unit of Nephrology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Cortinovis M; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Perna A; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Peracchi T; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Giuliano GA; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Rota S; Unit of Nephrology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Brambilla P; Unit of Radiology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Invernici G; Unit of Gastroenterology and Digestive Endoscopy, Azienda Socio-Sanitaria Territoriale, Bergamo Est, Alzano Lombardo, Bergamo, Italy., Villa D; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Diadei O; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Trillini M; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Natali G; Unit of Nephrology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Remuzzi G; Clinical Research Center for Rare Diseases 'Aldo & Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2021 Dec 14; Vol. 43, pp. 101227. Date of Electronic Publication: 2021 Dec 14 (Print Publication: 2022).
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Autor:
Chen Y; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China, 100853., Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A
Publikováno v:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2014 Oct 16 (10). Cochrane AN: CD004293. Date of Electronic Publication: 2014 Oct 16.
Autor:
Chen Y; Chinese People's Liberation Army General Hospital, Beijing, China., Schieppati A, Cai G, Chen X, Zamora J, Giuliano GA, Braun N, Perna A
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2013 May; Vol. 8 (5), pp. 787-96. Date of Electronic Publication: 2013 Feb 28.
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Autor:
Schieppati A; Renal Medicine, Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Mario Negri Institute for Pharmacological Research, Via Gavazzeni, 11, Bergamo, Italy, 24125. manuelap@marionegri.it, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G
Publikováno v:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2004 Oct 18 (4). Cochrane AN: CD004293. Date of Electronic Publication: 2004 Oct 18.